Oppenheimer analyst Jay Olson maintained a Hold rating on Nektar Therapeutics (NKTR – Research Report) today and set a price
Author: Christine Brown
Needham Thinks Esperion’s Stock is Going to Recover
Needham analyst Chad Messer reiterated a Buy rating on Esperion (ESPR – Research Report) today and set a price target
William Blair Thinks Sarepta Therapeutics’ Stock is Going to Recover
In a report issued on January 12, Tim Lugo from William Blair maintained a Buy rating on Sarepta Therapeutics (SRPT
Avino Silver & Gold (ASM) Gets a Buy Rating from Roth Capital
Roth Capital analyst Joseph Reagor maintained a Buy rating on Avino Silver & Gold (ASM – Research Report) today and
Antero Resources (AR) Gets a Sell Rating from Morgan Stanley
In a report released today, Mark Carlucci from Morgan Stanley maintained a Sell rating on Antero Resources (AR – Research
Brighthouse Financial (BHF) Gets a Hold Rating from Morgan Stanley
Morgan Stanley analyst Nigel Dally maintained a Hold rating on Brighthouse Financial (BHF – Research Report) today and set a
Equitable Holdings (EQH) Gets a Buy Rating from Morgan Stanley
In a report released today, Nigel Dally from Morgan Stanley maintained a Buy rating on Equitable Holdings (EQH – Research